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Introduction: Rheumatic Heart Disease (RHD) remains a major
public health problem in many parts of the world.1,2 Globally,
India contributes nearly 25%e50% of newly diagnosed cases,
deaths, hospitalizations and burden of RHD.1
Rheumatic Heart Disease (RHD) has been documented in Indian
medical literature since early 19th century. In the past 50 yrs, RHD
emerged as a major contributor for cardiovascular morbidity in
India.
Rheumatic Heart Disease (RHD) probably affects 1% of popu-
lation in our country and at least 8 million people suffer from
it.3 Prevalence rates from a large ICMR study vary from as high
as 39.6 per 1000 to as low as 1 per 1000 children. It causes
25e40% of all cardiovascular diseases in developing countries.4
22e50% of all cardiac patients seen in Indian hospitals have
RHD.5 50% of heart operations performed in our country is for
RHD (10). 28e45% of all cardiovascular deaths in our hospitals
are also due to RHD.5
The developed countries witnessed a dramatic decline in the
incidence of rheumatic fever (RF) and the prevalence of Rheu-
matic Heart Disease (RHD) in the 20th century; however, this has
continued to be a major health care concern in the developing
countries. In India, the prevalence of RF/RHD among school chil-
dren is 2e11 per 1000 with amean of 6 per 1000.6 Recently, a study
conducted by Jacob Jose in 2002 has shown the prevalence to be
0.68 per 1000 children.7 The adult average ranges between 123 and
200 per 100,000 population,8 when compared to industrialized
nations the incidence of RF is 0.5/100,000 population and preva-
lence less than 0.05/1000.9
Population-based epidemiological data to ascertain the preva-
lence of RHD in India are lacking.10 A properly planned population
study in 1993 reported a prevalence of 0.09% for RHD.8
The management of RHD is generally crisis-oriented, advising
each patient depending upon symptoms, diagnosis, suitability for
surgery and economic ability to meet its cost, accessible surgical
facilities etc. Anti rheumatic prophylaxis, often advised, is seldom
adhered to.
Prophylaxis against bacterial endocarditis before minor surgery
is seldom instituted. Consequently, the morbidity and mortality
due to the disease are considerable, causing great economic loss
to the individual, family and the country.http://dx.doi.org/10.1016/j.ihj.2014.02.014The epidemiology of rheumatic heart disease in India is of
special interest as it may help to understand the effects of eco-
nomic transition on this enigmatic disease. However, the cumu-
lative burden of the disease remains high, and sustained efforts
for the prevention of rheumatic heart disease are warranted.12
With this in view, Rheumatic Heart Disease Clinic was started
in 1985 in the General Hospital, Tata Tea Limited to identify all
individuals with RHD in the Company’s population, institute
medical treatment, secondary prevention of rheumatic fever
(R.F) and bacterial endocarditis prophylaxis, select suitable pa-
tients for surgery and refer them to appropriate centres, arrange
surgery and help in their rehabilitation.
This 150 bedded hospital caters to over one lakh population,
consists of tea plantation workers and their families in the High
Ranges around Munnar, Kerala. Company’s 24 estates, sprawled
over 500 sq.kms lie at elevations varying from 1300 m (4300 ft) to
1900 m (6200 ft) above mean sea level.
The Cardiac Clinic maintained patient records with clinical data,
X-Ray, ECG and Echocardiographic findings. Anti rheumatic and
endocarditis prophylaxis are instituted for all patients and metic-
ulously followed up. Medical treatment for congestive cardiac fail-
ure, arrhythmias etc, are instituted where required. Symptomatic
patients were reviewed every month and others once in 3 months.
Suitable patients for surgery, based on accepted clinical criteria,
were selected and referred to reputed tertiary care centers for
evaluation. Those accepted for surgerywere given allmonetary and
material support including arranging of blood donors. On returning
from surgery they were also helped in rehabilitation.
Presented below are the data of these patients followed up at
this hospital for the last 28 years from January 85 till December
2012
Observation: A total number of 554 patients which include 193
males (35%) and 361 females (65%) with Rheumatic Heart Disease
are identified and registered for follow up.
Clinical diagnosis is shown in Table 1. Mitral valve was
involved, either alone or in combination, in 484 patients (87%).
However, Mitral Stenosis (MS) alone was seen in 144 (26%)
Mitral Regurgitation in 101 (18%) Mitral Stenosis and Mitral
regurgitation (MSþMR) in 148 (26.71%) and Mitral with Aortic
valve disease in 66 patients (11.9%). Isolated Aortic valve
involvement seen in 52 (9.38%) with Aortic Stenosis (AS) in 10
(1.8%) Aortic Regurgitation (AR) in 12 (2.1%) AS with AR in 30
(5.14%) patients.
History of Rheumatic Fever is noted in only about 50% patients
with RHD. However, there is no clear data at present to suggest
that those without a history of Rheumatic Fever are in anyway
etiologically different from those with such history.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 2 5 5e2 6 1256Table 1 e Clinical diagnosis of valve involvement in
patients with RHD. n e 554.
Diagnosis Male Female TotalMitral Stenosis (MS) 43 101 144 (26%)Mitral Regurgitation (MR) 24 77 101 (18.2%)MS þ MR 48 100 148 (26.71%)
MVP 6 19 25 (4.5%)Aortic Stenosis (AS) 4 6 10 (1.8%)Aortic Regurgitation (AR) 8 4 12 (2.1%)AS þ AR 23 7 30 (5.4%)
Mitral þ Aortic valve disease 30 36 66 (11.91%)
Rh. Carditis Follow up 7 11 18 (3.2%)Total 193 361 554Table 2 records the major occurrences in the morbidity and
mortality profile of these patients. 58 patients lost follow up as
they left the district. 37 patients (6.67%) developed clinical fea-
tures of pulmonary hypertension of varying severity, 19 patients
(3.42%) developed atrial fibrillation, 4 patients had thromboem-
bolic complications and 2 had L.A.Clot. 83 patients (14.98%) with
far advanced disease died during this period in spite of optimum
medical treatment. This includes 2 after CMV, 1 each after MVR
and AVR.
Table 2 e Morbidity and mortality in patients with
rheumatic heart disease.
N (%)Pulmonary hypertension 37 (6.67)Atrial fibrillation 19 (3.42)L.A. Clot 2 (0.36)Embolic episode 4 (0.72)Post CMV restenosis 3 (0.54)Lost follow up 58 (10.46)Death 83 (15)Tertiary care evaluation was arranged for the 122 patients
(Table 3) and referral to a cardiac surgical center was done out of
whom 73 were operated, and the rest are under follow up. Closed
Mitral Valvotomy (CMV) was the commonest surgical procedure
performed (26 patients).
Table 3 e Care for 554 patients with rheumatic heart
disease.
(A) Referral for Cardiological Evaluation - 122
(B) Operated (n e 73)Closed mitral valvotomy - 26Balloon mitral valvotomy - 4Mitral valve replacement - 26Aortic valve replacement - 7Double valve replacement - 4P.T.M.C - 5LA Myxoma - 1Surgery fixed - 3Discussion: Though Solomon Victor and A. Sankaran3 state that
RHD affects one percent of our population, there are very few
population surveys to substantiate this. Padmavathy5 had
reviewed the available surveys and noted the following preva-
lence rates. Roy (1969)-2.2 per 1000 (Delhi) Berry (1972)-1.62 per
1000 (Urban population of Chandigarh) ICMR School Surgery (1972e 75)-6.3 per 1000. In the ICMR study, the schools of Alleppey,
Kerala had shown a prevalence rate of 2/1000. Prevalence rates
from a large ICMR study varies from as high as 39.6 per 1000 to as
low as 1 per 1000 children.13
Our observation yields a RHD prevalence rate of 5 to 6/1000
Sex distribution: In our observation, the prevalence in the male is
2/1000 and in the female 3.5/1000 with female preponderance.
This observation is similar to Dr.Berry’s observations in1972,14
where it was 1.23/1000 in males and 2.07/1000 in the female.
The school survey (ICMR) had 62% males 38% females. The
prophylaxis study of Padmavathy5 had 53.6% males and 46.4%
females. Malhotra and Gupta (1963) who reported a male pre-
ponderance and Agarwal (1969) and Sepaha (1965) who found
equal sex incidence. Bhatia15 holds the view that RHD in young
males occur more frequently as compared to females. Berry14
found no sex difference upto 15 years age group, but above 15
years female were preponderant and attributed hospital bias in
other studies.
Sainani16 felt that hospital based studies show that RHD is
commoner in men than women while community and field based
studies have shown quite the contrary. He attributed it to bias in
our country, which puts a greater value onmale life, and thus they
seek hospital services more often. Berry had held the same view
earlier (1972).14
In our setting, RHD prevalence with 35% in males and 65% in
females with a female preponderance is a truly unique data, as
this is both hospital based and population based as this is the only
hospital catering to the local captive population ensuring the
regular follow up.
Clinical diagnosis: Wahi17 had observed that, whereas hospital
based statistics do not reflect the extent of the disease in the
community, they truly reflect the distribution of valve involve-
ment. The clinical pattern of valve involvement in RHD reported
from various centers in India shows a predominant mitral valve
involvement followed by a combined mitral and aortic valve
disease with isolated aortic valve disease being very
uncommon.
Padmavathy5 had observed MS in 25%, MR in 49%, MS þ MR in
17% and Aortic disease in 9%. Bhatia (1976)15 also observed that
mitral valve lesions are the commonest and that isolated AR is
infrequent.
In our observation also Mitral valve was involved, either alone
or in combination, in 484 patients (87%). However, Mitral Stenosis
(MS) alone was seen in 144 (26%), Mitral Regurgitation (MR) in
101(18.2%) Mitral Stenosis and Mitral regurgitation in 148 (26.71%)
and Mitral with Aortic valve disease in 66 patients (11.91%) and
pure Aortic valve disease in 52 patients (9.38%).
Morbidity: A number of events occur in the life of the RHD patient,
which reflects the morbidity caused by the disease. CCF, LVF,
Atrial Fibrillation (AF), endocarditis, hemoptysis, embolic epi-
sodes etc, threaten the life of the patient and impairs its quality.
Efficient medical treatment can ameliorate the severity or im-
mediate consequences of these events but many would need
surgery once they become progressively more symptomatic. Pro-
phylaxis against RF and endocarditis assumes greater importance
in avoiding morbidity and mortality.
K.S. Iyer18 advises that features of PHT, onset of AF, history of
hemoptysis or embolic episodes constitute definite indications for
surgery in an otherwise asymptomatic or mildly symptomatic
patient. Severe PHT no doubt increases operative mortality
significantly but results of medical treatment are extremely un-
satisfactory and surgery is their only hope of survival.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 2 5 5e2 6 1 25737 patients (6.67%) developed clinical features of pulmonary
hypertension of varying severity, as indicated clinically by
increased parasternal lift, palpable P2 closure, Loud P2 component
of second sound, pulmonary artery dilation at hilum and periph-
eral pruning on X-Ray, ECG evidence of RVH and later RAH. 59%
of Padmavathy’s patients had PHT.12 Ours is probably less because
of early detection in the fields, well before they become
symptomatic.
19 patients (3.42%) developed atrial fibrillation and tolerated the
AF well with digoxin. S.K Sen (1982)19 felt that AF occurs so
frequently in the course of MS that it hardly qualifies as a compli-
cation of the disease. But it adds to the morbidity and mortality,
precipitates failure or an embolic episode. 4 (0.72%) patients had
thromboembolic complications and 2 (0.36%) had L.A.Clot.
Padmavathy cites Shawwho observed embolic episodes in 1% of
his cases. K.S. Iyer18 reports 4.3%. Incidence of embolic episodes,
massive hemoptysis, and acute pulmonary oedema was all quite
low in our series. All of our patients who had embolic episodes had
moderate to severe MS without AF.
All were treated with prompt anticoagulation. 3 of our patients
operated, developed clinical signs of restenosis/inadequate dila-
tation during this period.
Mortality: 83 patients (15%) with far advanced disease died during
this period in spite of optimummedical treatment. This includes 2
after CMV, 1 each after MVR and AVR. Padmavathy reported death
in 7.1% of her patients in her prophylaxis study (1966e74).
K.S.Iyer18 comments that natural history of untreatedMS can only
be assessed from data collected in the pre surgical era. He cites
Oleson who found a 62% 5 year and 38% 10-year survival in NYHA
class III patients and 15% 5-year survival in class IV patients.
58 patients (10.46%) were irregular and lost follow up. Padma-
vathy (1966-74) found in her prophylaxis study that 25.8% dropped
out and 9.1% irregular.
Surgery: Surgery is the best available mode of treatment for
chronic rheumatic heart disease but no surgery can restore a
diseased valve to normal, a reminder of the fact that the solution
to the problem of RHD lies not in sophisticated cardiac surgery but
in prevention of RF.18 There is no doubt that surgery improves the
course of rheumaticMS. It is indicated for any patient of MSwho is
symptomatic with NYHA class II or more.
122 patients selected on accepted clinical criteria were referred
for further Cardiological evaluation to assess suitability for sur-
gery of whom 73 were operated. CMV was performed in 26 pa-
tients. MVR was done in 26 patients. AVR in 7 patients and DVR in
4 patients. 5 patients underwent PTMC. 3 patients are awaiting
cardiac surgery.
Rehabilitation: A unique feature of our endeavor has been reha-
bilitation of these patients. Working patients have been helped to
undertake suitable work, capable within their effort tolerance.
Operated patients have been fully rehabilitated back into their
work.
Public health education: Berry (1976)14 advised that, one should
attempt to detect the disease early, institute chemoprophylaxis in
those with minimal damage and medical or surgical treatment in
those with more advanced disease. Such an approach would cut
down morbidity and mortality.
Padmavathy5 had felt in 1978 that early case finding at primary
school level, their prophylaxis, combined with surveillance of all
RHD cases appear to be the only solution to this important public
health problem and that establishment of well equipped cardiac
clinics with medical and surgical facilities are necessary for
treatment of those already afflicted with the disease.Wahi (1984)17 had said, “In India, strategies for primary and sec-
ondary prevention need great emphasis. Impossible logistics of pri-
maryprevention, coupledwithenormousfinancial constraints force
us to concentrate on secondary prevention. We should establish
Rheumatic Fever registry and follow up programme, provide drugs
for secondary prophylaxis, educate and provide basic facilities, both
diagnostic and therapeutic, at the village health worker level”.
Sainani (1984)16 had outlined the WHO programme for Asia and
Africa: 1) to acquire knowledge about the disease in those areas. 2)
Surveillance of known cases. 3) Study feasibility for control. They
recommended 1) RHD clinics to be set up. 2) Accurate diagnosis
and follow up of all referred cases. 3) Maintenance of a registry. 4)
Secondary prophylaxis with Benzathine Penicillin. 5) Close follow
up, as dropout rates are high. We have put into practice many of
the recommendations of experts in India.
Conclusion: We have presented our Hospital and population
based data of follow up of patients with RHD to present our
findings on the prevalence, distribution, morbidity and mortality
of RHD in a population of over 1 lakh plantation workers, living in
a unique geographical and climatic setting. We believe that our
efforts in this field have directly helped the community to reduce
the morbidity and mortality due to the diseases.
It is of vital importance to develop effective public health stra-
tegies for prevention and control of RHD. Surgical corrections of
valvular lesions are associated withmorbidity andmortality apart
from financial and anticoagulant monitoring problems.
The likely measures to control RF/RHD in present state are Pri-
mary prophylaxis by treatment of all sore throats Secondary
prophylaxis by early detection at the primary stage of RHD.
In conclusion, RHD continues to remain a major cardiac illness
with an enormous disease burden that translates into huge eco-
nomic and social losses. RHD is not gone, but forgotten. The
decline in the incidence of RF/RHD in the developed world has
unfortunately resulted in a parallel decline in the research interest
in this disease.References
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Non-invasive assessment of right ventricular
function in patients of rheumatic mitral stenosis
and immediate effect of percutaneous
transvenous mitral commissurotomy on it
Pawan Kumar Ola, Ranjit Kumar Nath, Neeraj Pandit
PGIMER, Dr RML Hospital New Delhi, India
Background: Mitral stenosis (MS) affects right ventricular (RV)
function as a result of myocardial and hemodynamic factors. RV
function is the major determinant of clinical outcomes.
Aims and objectives: The aim of this study was to evaluate RV
function in rheumatic MS patients and to evaluate the immediate
effect of percutaneous transvenous mitral commissurotomy
(PTMC) on it. Andwhether it can be a criteria for early intervention
in patients of rheumatic MS in whom there is difficulty in
assessing pulmonary hypertension.
Methods: In this study we enrolled a total of 86 consecutive pa-
tients (58 females, 28 males) with isolated rheumatic MS, all in
sinus rhythm, undergoing PTMC between August 2011 to July
2013. Patient’s mean age was 24  7 years. All patients underwent
successful PTMC by anterograde transseptal approach using an
Inoue balloon. Right ventricular systolic pressure (RVSP) and
tricuspid annular plane systolic excursion (TAPSE), a parameter of
RV longitudinal function were assessed by conventional echo-
cardiography, while peak systolic (Sm), peak early diastolic (Em)
and peak late diastolic (Am) annular velocities of tricuspid valve
annulus were assessed by tissue Doppler imaging echocardiog-
raphy. All these parameters were assessed before and on the next
day after PTMC.Results: Next day after successful PTMC, TAPSE increased from
16.11  2.1 mm to 19.13  2.59 mm (p < 0.05), Sm increased from
10.30  1.6 cm/s to 13.26  1.37 cm/s (p < 0.05) and Em/Am ratio
increased from 1.15  0.12 to 1.57  0.17 (p < 0.05). There was a
significant decrease in RVSP from 56.4  18.6 to 27.2  11.4
(p < 0.05).
Conclusion: TAPSE and tricuspid annulus tissue Doppler indices
were able to assess RV dysfunction in rheumatic MS patients and
they were significantly improved in the immediate post PTMC
period. So, the assessment of RV dysfunction can be a simple,
non-invasive criteria for intervention in patients of rheumatic MS
specially in those patients in which there is difficulty in assessing
pulmonary hypertension. Though further work using larger
number of patients is needed to confirm our findings.Aortic pulse wave velocity and its correlation
with complexity of coronary artery disease based
on syntax score
R. Ranjith, T.G. Binu, VijoGeorge, K.G.Madhu, Subair Kunju, R. Baiju,
V. Jayaram, K.S. Mohanan, V.V. Radhakrishnan
Govt. T.D Medical College Alappuzha, India
Background: Aortic pulse wave velocity (APWV), a marker of
arterial stiffness has been shown to be a good predictor for pres-
ence of incipient vascular disease and cardiovascular mortality in
observational studies. Since treadmill testing, stress & radio
nucleotide studies can have limited specificity in diagnosing CAD,
other methods are required.
Aims & objectives: There are few reports demonstrating a rela-
tionship between aortic pulse wave velocity findings and the
complexity of coronary artery disease. We aimed to examine the
relationship between APWV findings and the severity of the
SYNTAX scores (SXscore). The relationship of other non-invasive
vasculopathic indices like Common Carotid artery intima media
thickness (CCIMT) & Ankle brachial index (ABI) with advancing
CAD were also analysed.
Methods: Subjects were 500 consecutive patients who underwent
APWV measurements and first coronary angiography from
December 2012 to June 2013.Pulsed Doppler ultrasound with a
Linear Array (6.6 MHZ) probe, synchronized with ECG and a two-
second minimum sliding window (MyLab 50, Esaote, Florence,
Italy) was used to calculate APWV. All APWVmeasurements were
taken by same observer. SYNTAX scoring was performed by ob-
servers who were blinded to APWV scores. Mean carotid intima
media thickness (CIMT) & Mean Ankle brachial index (ABI) were
measured as per ASE/ACC/AHA Guidelines.
Results: A significant, nearly linear correlation between APWV
and advancing CAD (p < 0.0001) was found. Patients with two and
three vessel CAD had significantly higher APWV than patients
without CAD. Even though mean APWV was higher in patients
with Single vessel disease compared to subjects with normal
coronaries, the difference was not statistically significant. It was
also found that mean APWV values were significantly more in
patients with high or intermediate SYNTAX scores than in pa-
tients with low syntax scores. The Fischer’s linear discriminant
analysis showed, cut off value of APWV for predicting the possi-
bility of having CAD to be >11.5 m/s. Other vasculopathic indices
(CCMIT & ABI) also showed positive correlation with advancing
CAD.
Conclusion:Aortic pulse wave velocity has predictive value for the
SXscore. There is a strong correlation between arterial stiffness
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 2 5 5e2 6 1 259and coronary atherosclerosis and APWV measured by 2D Doppler
is a good predictor of advancing CAD. Hence it can be used cost
effectively as amarker in prediction of pre-clinical atherosclerosis
andmulti vessel CAD. APWVmeasured by Doppler combinedwith
other non-invasive vasculopathic indices measurement (CCMIT &
ABI) increases the predictive value for advancing CAD.Impact of hepatic cyst on atrial haemodynamics
(abstract)
Sadath Pareed, G. Vijayaraghavan
Kerala Institute of Medical Sciences, Trivandrum, Kerala 29, India
Case No: 1 61 year male presented with dyspnea. He was diag-
nosed to have systemic hypertension, polycystic kidney disease,
End Stage Renal Disease and was on regular haemodialysis. JVP
was elevated for 15 cm. There were no other clinical findings.
Chest x-ray showed elevated right hemidiaphram and ECG was
normal. Echocardiogram showed atrial septal aneurysm buldging
into the left atrium. Four chamber view showed large mediastinal
mass compressing the right atrium. Patient underwent right sided
nephrectomy with deroofing of a hepatic cyst. Post operative JVP
was normal and echocardiogram revealed septal aneurysm
buldging into the right atrium. External compression by the
mediastinalmass raised the right atrial pressurewhich resulted in
atrial septal aneurysm to buldge into left atrium. After debulking,
pressure in the right side of the heart came down and normal
increase of pressure in the left side of the heart pushed the septal
neurysm into the right atrium.
Take home message: Dyanamic changes in atrial pressure will
resulting in the changing character of atrial septal aneurysm.Eight year experience of providing free
pacemakers to poor patients e the power of
partnership
Vijaya Bharat, B. Prakash, A. Jaiswal
Background: In the era of corporate hospitals, providing medical
facility to poor patients is a challenge. An industrial hospital in
Eastern India accepted the challenge and established a Free
Pacemaker Bank.
Aim: To share the experience of developing a system for providing
free pacemakers to poor patients
Method: We considered several options for providing pacemakers
to poor patients and selected the Rotary Heart Beat International
(HBI). HBI, a not-for-profit organization in the USA coordinates
with Pacemaker manufacturers who donate new devices for
needy patients anywhere in the world. The devices are distributed
through pacemaker banks governed by Rotary Clubs affiliated to
HBI. The implant team and the hospital are credentialed by HBI to
ensure patient safety and accountability. Information about each
implant and follow up data are monitored at HBI. Through the
efforts of a Rotary Club in Eastern India a pacemaker bank was
established in the year 2005. A large secondary care hospital was
approved by the HBI as the implant center. The management of
the industry to which the hospital is attached, agreed to waive off
the implantation charge in poor patients. The owner of a mining
industry from another Rotary Club volunteered to provide the
annual membership fee of US $ 5000 to HBI. Batches of new
pacemakers were sent from HBI as per requirement. Standardprocedures for case selection, implantation and follow up were
observed.
Result: From March 2005 till June 2013, 140 devices were implan-
ted in 136 poor patients from Jharkhand, Bihar, Orissa and West
Bengal. The patients, evaluated by local physicians were sent by
Rotary clubs. One of the beneficiaries was a poor patient from
Kabul in Afghanistan, referred by a Rotary Club in Kolkata. There
were 101 males and 35 females. Their age ranged from 20 to 86
years. Devices of various brands like Medtronic (59), Biotronic (36),
St Jude (27), Vitatron (13), and Guidant (5) were used. We
implanted 89 devices for dual chamber pacing and 45 for single
chamber pacing. Cardioverter/ defibrillator devices were implan-
ted in five patients with ventricular tachycardia and a CRT device
in a patient with heart failure. Complications included one each of
lead displacement, pneumothorax and superficial surgical site
infection in three patients that were recognized and managed. All
the patients were followed up in the weekly Pacemaker Clinic, as
per the recommended intervals. Four dual chamber devices that
reached end of life five to seven years after the primary implan-
tation were replaced with new pacemakers under the same
scheme.We started RVOT pacing with the screw in leads provided
by HBI (in 16 patients). The experiences gained were shared in
conferences in India and the HBI arrhythmia workshops held
along with the Annual Conferences of the American College of
Cardiology at Chicago, New Orleans and Atlanta. The interactions
were educative and a paper on RVOT pacing was published in a
Canadian journal. In June 2013, the President of Rotary Interna-
tional awarded the physician for humanitarian service rendered
through the Pacemaker project.
Conclusion: We could successfully establish a facility that pro-
vided free pacemakers to poor patients. It could be sustained over
eight years through partnership with NGOs. The win-win situa-
tion helped the patients, fulfilled corporate social responsibility of
industries and gave valuable experience to the team.Partial splenic embolisation in patients with
hypersplenism
Subhendu Mohanty, Sumod Kurien, Saibal Mukhopadhyay, Girish
M.P., Mohit D. Gupta, Partha P. Chowdhary, Mohan Kumar H.N.,
Vijay Kumar Trehan, Sanjay Tyagi
GB Pant Hospital, New Delhi, India
Background: Hypersplenism is common in patients with portal
hypertension, exposing them to high chances of infection,
bleeding risk and many other complications. Splenectomy re-
lieves features of hypersplenism but is a major surgery with
associated complication risk. Splenic embolisation has been sug-
gested as a possible effective alternative to this major surgery.
Aims and objectives: To assess the efficacy, safety and possible
complications with partial splenic embolisation in
hypersplenism.
Methods: 11 patients (7 males, 4 females), aged between 16-42
years, with portal hypertension and features of hypersplenism
were subjected to a partial splenic embolisation. This was ach-
ieved by selective catheterisation of the splenic artery followed by
injection of polyvinyl alcohol particles into the artery to ensure a
patchy moth eaten appearance of the spleen upon dye injection.
This phase is accompanied by a slow, but definite, clearance of
injected dye. The complete blood count (CBC) was repeated on day
1,4,7 and 10.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 2 5 5e2 6 1260Results: There was an immediate rise in the CBC which peaked
by day 7 in most patients. Pain in abdomen (63%, 7 patients) and
vomiting (45%, 5 patients) were the most common complica-
tions and occurred within 12 hours (average 4 hours) of the
procedure. No major in-hospital complications were noted.
Average hospitalisation was for 5 days post procedure. The table
shows the average cell count before and 10 days after the pro-
cedure.
WBC count Platelet count RBC count
(per ml) (per ml) (per ml)Pre 850 16000 3.5  106
Post 10500 205000 5.7  106The patients were followed up for an average of 3 months (15
days e 5 months). The CBC count continued to be normal and no
log term complications were reported.
Conclusion: Partial splenic embolisation is a safe and effective
therapeutic mode for patients with hypersplenism.Circulating levels of regulatory t cells in
rheumatic heart disease
Saibal Mukhopadhyay, Mohan Kumar H N, Saurabh Varma, Jamal
Yusuf, Subhendu Mohanty, Vijay Trehan, Sanjay Tyagi
GB Pant Hospital, New Delhi, India
Background and aim of the study: Rheumatic heart disease (RHD)
is an autoimmune disease, where progressive valvular destruc-
tion is mediated by effector T cells sensitised against heart valve
antigens mimicking streptococcal antigens. Regulatory T (Treg)
Cells can inhibit these effector T cells and arrest /prevent pro-
gressive valvular damage. In a preliminary study, we reported
Treg cells (defined as CD4 þ CD25 þ cells) are decreased in RHD.
But numbers of recent studies have reported that markers like
CD4/CD25 cannot reliably differentiate regulatory from effector T
cells. CD4 þ CD25 þ Tcells with high CD25 and low CD127 have
been defined as Tregs, which has been used in the present study to
assess Treg level.
Methods: A total of 80 adult patients with chronic RHD (40 each of
univalvular and multivalvular left sided disease assessed by
echocardiography) and 40 age and gender matched controls will
be studied. Levels of circulating Tregs were determined using flow
cytometry.
Results: Data of 80 patients (40 each of Univalvular and multi-
valvular) and 40 controls have been analysed. The mean per-
centage of T Regulatory (CD4þCD25þCD127low) cells in
lymphocytes was 22.5þ/18.8 in the RHD group, 23.34þ/19.9 in
the Univalvular group, 21.68þ/-17.9 in multivalvular group and
31.3þ/27.15 in control group. Though Tregs were decreased in
both Univalvular and multivalvular group compared to controls,
only difference between RHD group and control achieved statis-
tical significance (P ¼ 0.0395).
Conclusion: Tregs are significantly decreased in patients of
chronic RHD patients, with more reduction seen in multivalvular
involvement. The replacement of regulatory T cells may attenuate
the rheumatic process and improve, or at least prevent, the pro-
gression of rheumatic valvular heart disease.Obstructive left main coronary disease; clinical
profile and angiographic characteristics
Binu. T.G.*, Madhu.K.G., Ranjith.R, VijoGeorge, Mohan.K.S.,
Jayaram.V., Subairkunju, Radhakrishnan.V.V.
Department of Cardiology, Government T.D Medical college, Alappuzha,
Kerala, India
Background: To analyze the clinical and angiographic character-
istics of patients with obstructive left main coronary
disease(LMCAD).
Methods: In this descriptive study patients with left main coro-
nary artery disease who underwent CAG in MCH, Alappuzha were
evaluated. Those with obstructive LMCA disease of 50% or more
luminal narrowing were included. Clinical characteristics, risk
factors and angiographic findings were recorded.
Results: Out of 2100 angiograms done during the study period, 110
obstructive left main disease cases (¼/>50% luminal narrowing)
were detected. Patients with obstructive LMCAD had mean age
of60 years. Male and female were 70.9% and29.1%respectively.
Diabetes mellitus (34.5%), hypertension (64.5%), dyslipid-emia
(40.9%) and smoking (42.7%)were main risk factors. Stable angina
was seen in 67.3%, STEMI in 46.4%, unstable angina in 30.9% and
NSTEMI in7.3%. 75.4% had ST-elevation (>0.05 mV) in lead aVR.
Mean ejection fraction was50%. Ostial, midshaft and distal bifur-
cating disease was seen in22.7%, 8.2% and 69.1%, respectively. In
distal bifurcating LMCAD, LAD was involved in 41.8% and LCx in
27.3%. TVD (62.7%), DVD (28.2%), SVD (8.2%), LMCA alone (0.9%)
were seen. In women 68.8% had distal, 25% had ostial, 6.2% had
mid-shaft LMCAD. Patients with more than 3 risk factors had 73%
distal, 21.6% ostial, 5.4% mid LMCAD. Among them, 32.7% under-
went CABG, 66.3% hadmedical follow up, 1 patient underwent PCI.
Mean follow up period was 11 months. Patients who underwent
CABG,most of themwereasymptomatic (87.5%), 1(6.3%) hadACS, 1
died in the immediate post-operative period. In Medical follow up
group, 72.3%, had stable angina, 8 patients (12.3%) had unstable
angina, 1 died during follow up. One patient underwent PCI and
was asymptomatic during the follow up period. In medical group,
subgroup analysis of patients withMACE/ death showed that all of
themhad agemore than 50 yrs, 88.9%weremales, 77.8% hadmore
than3risk factors, 55.5%presentedwith stableanginaat the timeof
CAG, 88.9% had distal LMCAD, 88.9% had TVD,88.9% had a high
syntax score of more than 38.
Conclusion: Age more than 50, unstable angina, ST elevation in
aVR and co-existent TVD were the common denominators. Distal
LMCA is most commonly affected. LMCAD is a heterogeneous
group. Patients with low risk with a low syntax score can undergo
medical therapy safely.Can we attempt PCI guide wire to open occluded
coronaries through Diagnostic catheters without
changing to Guiding catheters in untoward
situations? e A case report
Janardhana Rao Babburi, Robert, Jyothsna, Murali, Vijay
Apollo Heart Institutes, Apollo Hospitals, Hyderabad, Andhra Pradesh,
India
A 54 year old male, a known case of Hypertension presented with
history of epigastric discomfort of 5 hours duration. He is also a
known caseof duodenal ulcer (DU)withdeformedduodenal bulb by
UGI scopy 2 weeks prior to admission. Initial ECG was normal. He
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 2 5 5e2 6 1 261was admitted under medical gastroenterology in view of UGI
symptoms. He developed severe chest pain after 4 hours of admis-
sionandECG taken that timeshowedevolvingacute inferiorwallMI
changes. After explaining the risks he was thrombolysed with ten-
ecteplase. ECHO done showed RWMA in RCA territory with EF 48%.
Post thrombolysis, painbecamebetter andECGchanges also started
settling.After stabilization,hewas takenup for coronaryangiogram
(CAG). Angiogram showed Single Vessel Disease (SVD) with Prox-
imal LCXhaving 80 to 90% lesionwithnormal RCAand LAD.Hewas
planned for PCI and PCI was done with Drug Eluting Stent (DES) by
direct stenting through right femoral approach.
Post PCI, within 2 hours the patient had gone into hypotension
with a BP of 70 mm hg systolic. Patient had no chest pain or
discomfort in spite of hypotension and serial ECGs did not give any
evidence of stent thrombosis. As he did not improve hemodynam-
ically even after giving IV fluids and ionotropic supports, he was
taken up for check angiogramaswe suspected the possibility of sub
acute stent thrombosis. We went through right radial approach
using 5F Brachial Type Tiger catheter. Initial check angiogram cine
taken showed complete occlusion of the LAD coronary and slow
flow noted across the stented LCX. After the 1st cine angiogram,
patient immediately had episodes of continuous VT with severe
chest pain and patient became restless. The fibrillating ventricle
with completely occluded LAD was saved in the cine angiograms.
We concluded that the cause of VT (Ventricular Tachycardia)
was due to migration of thrombus into the LAD, which was
completely normal in angiogram and slow flow in LCX. As he was
restless, we had no time to change to Guiding catheter. Immedi-
ately with the same 5F Brachial Type Diagnostic catheter, we just
passed a BMW wire and tried to open the occluded LAD. We did
not give him DC shock or any anti arrhythmic drugs. With
manipulation of BMW wire at the ostium of LAD, the flow in LAD
was restored and after giving the intra coronary cock tail regimen,
the flow was restored completely and the VT was totally dis-
appeared and gradually the chest pain also settled. After the intra
coronary cocktail, the flow in LCX also completely restored, and
patient became hemodynamic ally stable.
The logical thinking and timing of immediate intervention is
very important in cases when there is hemodynamic compromise
without any evidence of ECG changes or symptoms after any
coronary intervention. The immediate intervention in cases like
these would save the lives of the patients. The immediate revas-
cularization of the occluded vessel is important at times when
there is no time to change the Diagnostic catheter. The opening of
the culprit vessel is important in the cases like these when there is
sudden onset of VT due to abrupt closure of the vessel or hemo-
dynamic compromise during the procedure rather than delaying
in changing the catheters.A multicentric, retrospective, outcome analysis
of contemporary antiplatelet discontinuation
practices in coronary artery disease patients
undergoing cardiac/non cardiac surgeries
Priyadarshini Arambam, Upendra Kaul, Dheeraj Gandrota
Fortis Escorts Heart Institute and Fotis Hospital Vasant Kunj, New Delhi,
India
Background: Patients with coronary artery disease (CAD) poses
cardiologists, surgeons, and anesthetists with the dilemma of
deciding between the risk of increased blood loss when
continuing antiplatelet agents in the peri-operative period, and
the risk of thromboembolic events if the drugs are stopped.
Aim: Analysis of the data, on the current practices of continuation
or discontinuation of anti-platelets in CAD patients undergoing
cardiac/non-cardiac surgery. In addition to observe adverse
events resulting from this practice.
Methods: Multi centric, retrospective, observational study con-
ducted in three tertiary care centers of India. A minimum 1537
patients with CAD undergoing surgeries will be included in the
study. The Primary outcome of the study is peri-operative
thromboembolic events - stroke, pulmonary embolism, deep
vein thrombosis and acute coronary syndromes and the second-
ary outcome is Peri-operative bleeding. Bleeding was classified as
major (Type 2 to 5) and minor (Type 0 and 1) as per the BARC
definition of bleeding.
Results: In this ongoing study 500 patients have been enrolled.
The average age of the patients was 51 yr out of these 85.4%
were male. 412 (82.4 %) of patient underwent cardiac surgery
and out of this 78 (18.9%) continued the therapy and 334 (81%)
discontinued the therapy. 88 (17.6%) patient under went
noncardiac surgery and out of this 19 (21.5%) patient continued
the therapy and 69 (78.4%) discontinued the therapy. Of the
patients who had discontinued anti platelets, major bleeding
was seen in 215 (87.7%) patients and 30 (12.2 %) had minor
bleeding. On the other hand major bleeding was seen in 25
(69.4%) patients and minor bleeding was seen in 11 (30.5%)pa-
tient who continued antiplatelet therapy in the cardiac surgery
group. Of the 88 patients who underwent non cardiac surgery,
major bleeding was seen in 1 (1.4%) patient who discontinued
drugs. However in the group who did not discontinue anti
platelets, major bleeding occurred in 2(66.6%) patients with
minor bleeding in only 1 (33.3%).
Conclusion: The thrombotic events do not seem to be influenced
by continuing or discontinuing anti platelet therapy. Complete
data of 1537 patients will be presented.
